About Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia
During the past decade, Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia"
#1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia
According to Clinical.Site data, the most researched conditions in "Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia" are
"Non-Hodgkin's Lymphoma" (2 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia" in a lesser frequency.
Clinical Trials Intervention Types at Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia
Most popular intervention types in "Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (2 trials), "Chemotherapy (Induction Period)" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia
The vast majority of trials in "Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia" are
3 trials for "All" genders.
Clinical Trials Status at Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia
Currently, there are NaN active trials in "Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Uni Di Verona Policlinico G.B. Rossi; Divisione E Cattedra Di Ematologia, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".